PEPTIDES DESTINES A ETRE UTILISES DANS LE TRAITEMENT ET LE DIAGNOSTIC DU DIABETE DE TYPE 1
- 专利权人:
- IMMUSANT; INC.
- 发明人:
- ANDERSON, ROBERT P.
- 申请号：
- CA2968422
- 公开号：
- CA2968422A1
- 申请日:
- 2015.11.20
- 申请国别(地区):
- CA
- 年份:
- 2016
- 代理人:
- 摘要：
- Provided herein are compositions and methods for treating autoimmune diabetes such as type 1 diabetes (T1D), diagnosing autoimmune diabetes such as T1D, assessing treatment efficacy, and selecting subjects for treatment, e.g., using a peptide or epitope disclosed.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Peptides for use in treatment and diagnosis of type 1 diabetes
- Peptides for use in treatment and diagnosis of type 1 diabetes
- 用於治療和診斷1型糖尿病中使用的肽
- improved synergistic composition； method of prophylactic or therapeutic treatment of diabetes； method of improving the effectiveness of treating sulfonylurea diabetes in an individual receiving sulfonylurea antidiabetic therapy； method of treating hyperglycemia； and method of preventing development or amelioration of side effects or conditions in an individual treated with a sulfonylurea and / or a sulfonamide and / or derivatives and / or metabolites thereof.
- METHOD FOR ASSESSING EFFECTIVENESS OF CORRECTION IN EXPERIMENTAL DIABETES MELLITUS TYPE 1
